Lannett intros generic Lescol
Fluvastatin sodium ER tablets had a market value of approximately $10 million for the 12 months ended May 2021, although actual generic market values are expected to be lower, according to IQVIA.
Lannett is offering fluvastatin sodium extended-release tablets, 80 mg, a partnered product.
The product is the generic of Novartis' Lescol XL tablets.
It is used as an adjunct to diet to treat elevated cholesterol levels.
Fluvastatin sodium ER tablets had a market value of approximately $10 million for the 12 months ended May 2021, although actual generic market values are expected to be lower, according to IQVIA.
"Although the market potential is modest, we are pleased to offer an affordable Fluvastatin alternative to our customers," said Lannett CEO Tim Crew. "Currently, only one other competitor markets generic Fluvastatin Sodium Extended-release Tablets, 80 mg, in the United States."